Gallic Acid Methyl Ester

Gallic Acid Methyl Ester

SCHEMBL21611341

COC(=O)c1cc(O)c(O)c(O)c1.[Ar]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.95
LMNA P02545 3/20 0.95
XDH P47989 2/20 0.95
POLB P06746 2/20 0.95
FUT7 Q11130 2/20 0.95
TDP1 Q9NUW8 2/20 0.95
GAA P10253 1/20 0.95
NFKB1 P19838 1/20 0.95
GFER P55789 1/20 0.95
NFKB2 Q00653 1/20 0.95
RELA Q04206 1/20 0.95
L3MBTL1 Q9Y468 1/20 0.95
CA12 O43570 3/20 0.61
CA1 P00915 3/20 0.61
CA2 P00918 3/20 0.61
CA7 P43166 3/20 0.61
CA9 Q16790 3/20 0.61
CA14 Q9ULX7 3/20 0.61
SERPINE1 P05121 6/20 0.57
CNR2 P34972 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gallic Acid Methyl Ester SCHEMBL39513 0.98 KDM4E (1.00) KDM4ELMNAXDHPOLBFUT7
Gallic Acid Methyl Ester SCHEMBL28507408 0.95 KDM4E (0.95) KDM4ELMNAXDHPOLBFUT7
Gallic Acid Methyl Ester SCHEMBL21543905 0.95 KDM4E (0.95) KDM4ELMNAXDHPOLBFUT7
Gallic Acid Methyl Ester SCHEMBL28556619 0.95 KDM4E (0.95) KDM4ELMNAXDHPOLBFUT7
Gallic Acid Methyl Ester SCHEMBL28108826 0.90 XDH (0.84) KDM4ELMNAXDHPOLBFUT7
Gallic Acid Methyl Ester SCHEMBL10713441 0.90 KDM4E (0.84) KDM4ELMNAXDHPOLBFUT7
Gallic Acid Methyl Ester SCHEMBL18585302 0.90 XDH (0.84) KDM4ELMNAXDHPOLBFUT7
Gallic Acid Methyl Ester SCHEMBL18585459 0.90 XDH (0.84) KDM4ELMNAXDHPOLBFUT7
Gallic Acid Methyl Ester SCHEMBL11657891 0.88 LMNA (0.81) KDM4ELMNAXDHPOLBFUT7
SCHEMBL23015432 0.86 POLB (0.78) KDM4ELMNAXDHPOLBFUT7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11407743-B2 Amphiphilic and mesogenic organic dyes for tailor-made reflective low-dimensional materials SORBONNE UNIVERSITE (FR) 2022-08-09 US disclosed
EP-3818039-A1 AMPHIPHILIC AND MESOGENIC ORGANIC DYES FOR TAILOR-MADE REFLECTIVE LOW-DIMENSIONAL MATERIALS Centre National de la Recherche Scientifique (CNRS) (FR) 2021-05-12 EP disclosed
US-20210122742-A1 Amphiphilic and Mesogenic Organic Dyes for Tailor-Made Reflective Low-Dimensional Materials UNIVERSITÉ PARIS CITÉ (FR) 2021-04-29 US disclosed
WO-2020008052-A1 AMPHIPHILIC AND MESOGENIC ORGANIC DYES FOR TAILOR-MADE REFLECTIVE LOW-DIMENSIONAL MATERIALS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2020-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210122742-A1 Amphiphilic and Mesogenic Organic Dyes for Tailor-Made Reflective Low-Dimensional Materials MITF, LRAT, APOL1 KDM4E 4058/4885LMNA 747/4885XDH 4491/4885
US-11407743-B2 Amphiphilic and mesogenic organic dyes for tailor-made reflective low-dimensional materials MITF, LRAT, APOL1 KDM4E 4058/4885LMNA 747/4885XDH 4491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.